Company Epirus Biopharmaceuticals Inc Nasdaq
Equities
US29428P1075
Biotechnology & Medical Research
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 26,184,349 | 26,184,349 ( 100.00 %) | 0 | 100.00 % |
Company contact information
EPIRUS Biopharmaceuticals, Inc.
699 Boylston Street 8th floor
02116, Boston
+617-600-3497
![address Epirus Biopharmaceuticals Inc](https://cdn.zonebourse.com/static/address/16933088.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+17.72% | 44.87B | |
-10.33% | 37.8B | |
+41.22% | 37.61B | |
+29.36% | 31.32B | |
-8.44% | 27.4B | |
+12.45% | 26.32B | |
+44.19% | 14.07B | |
+31.93% | 12.5B | |
-7.67% | 11.23B |